Cargando…

Mucosal immunization with Ad5-based vaccines protects Syrian hamsters from challenge with omicron and delta variants of SARS-CoV-2

SARS-CoV-2 variant clades continue to circumvent antibody responses elicited by vaccination or infection. Current parenteral vaccination strategies reduce illness and hospitalization, yet do not significantly protect against infection by the more recent variants. It is thought that mucosal vaccinati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Braun, Molly R., Martinez, Clarissa I., Dora, Emery G., Showalter, Laura J., Mercedes, Annette R., Tucker, Sean N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992185/ https://www.ncbi.nlm.nih.gov/pubmed/36911687 http://dx.doi.org/10.3389/fimmu.2023.1086035

Ejemplares similares

Efficacy of ChAdOx1 vaccines against SARS-CoV-2 Variants of Concern Beta, Delta and Omicron in the Syrian hamster model
por: van Doremalen, Neeltje, et al.
Publicado: (2022)

Efficacy of vaccination and previous infection against the Omicron BA.1 variant in Syrian hamsters
por: Halfmann, Peter J., et al.
Publicado: (2022)

SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters
por: Mohandas, Sreelekshmy, et al.
Publicado: (2021)

Protective efficacy of COVAXIN® against Delta and Omicron variants in hamster model
por: Yadav, Pragya D., et al.
Publicado: (2022)

ChAdOx1 nCoV-19 (AZD1222) or nCoV-19-Beta (AZD2816) protect Syrian hamsters against Beta Delta and Omicron variants
por: van Doremalen, Neeltje, et al.
Publicado: (2022)

Comparative pathogenicity of BA.2.12, BA.5.2 and XBB.1 with the Delta variant in Syrian hamsters
por: Mohandas, Sreelekshmy, et al.
Publicado: (2023)

Syrian hamster convalescence from prototype SARS-CoV-2 confers measurable protection against the attenuated disease caused by the Omicron variant
por: Ryan, Kathryn A., et al.
Publicado: (2023)

The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters
por: Abdelnabi, Rana, et al.
Publicado: (2022)

A trifunctional peptide broadly inhibits SARS-CoV-2 Delta and Omicron variants in hamsters
por: Zhao, Hanjun, et al.
Publicado: (2022)

Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern
por: Mohandas, Sreelekshmy, et al.
Publicado: (2022)

Detection of natural cytotoxicity in Syrian hamsters.
por: Rees, R. C., et al.
Publicado: (1980)

Reduced airborne transmission of SARS-CoV-2 BA.1 Omicron virus in Syrian hamsters
por: Boon, Adrianus C. M., et al.
Publicado: (2022)

LYMPHOCYTIC CHORIOMENINGITIS IN THE SYRIAN HAMSTER
por: Smadel, J. E., et al.
Publicado: (1942)

The Experimental Use of Syrian Hamsters
por: Valentine, Helen, et al.
Publicado: (2012)

Molnupiravir (MK-4482) is efficacious against Omicron and other SARS-CoV-2 variants in the Syrian hamster COVID-19 model
por: Rosenke, Kyle, et al.
Publicado: (2022)

Infection, pathology and interferon treatment of the SARS-CoV-2 Omicron BA.1 variant in juvenile, adult and aged Syrian hamsters
por: Yuan, Lunzhi, et al.
Publicado: (2022)

A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model
por: Ma, Jian, et al.
Publicado: (2023)

Aflatoxin induced lesions in Syrian hamsters.
por: Herrold, K. M.
Publicado: (1969)

Generation of transgenic golden Syrian hamsters
por: Gao, Mingming, et al.
Publicado: (2014)

A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge
por: Zhou, Biao, et al.
Publicado: (2022)

Protective Immunity of the Primary SARS-CoV-2 Infection Reduces Disease Severity Post Re-Infection with Delta Variants in Syrian Hamsters
por: Mohandas, Sreelekshmy, et al.
Publicado: (2022)

Pulmonary lesions following inoculation with the SARS-CoV-2 Omicron BA.1 (B.1.1.529) variant in Syrian golden hamsters
por: Rissmann, Melanie, et al.
Publicado: (2022)

Comparative pathology of VIC01 isolate and Omicron variant of SARS-CoV-2 infection, including a rechallenge model, in the Golden Syrian hamster
por: Rayner, E., et al.
Publicado: (2023)

duper is a null mutation of Cryptochrome 1 in Syrian hamsters
por: Lee, Yin Yeng, et al.
Publicado: (2022)

The Omicron Sub-Variant BA.4 Displays a Remarkable Lack of Clinical Signs in a Golden Syrian Hamster Model of SARS-CoV-2 Infection
por: Davies, Elizabeth R., et al.
Publicado: (2023)

Foodborne Transmission of Nipah Virus in Syrian Hamsters
por: de Wit, Emmie, et al.
Publicado: (2014)

New Semi-dominant Mutation in the Syrian Hamster
por: FESTING, M. F. W., et al.
Publicado: (1972)

Influenza Viruses Suitable for Studies in Syrian Hamsters
por: Fan, Shufang, et al.
Publicado: (2022)

Golden Syrian Hamster Models for Cancer Research
por: Wang, Zhongde, et al.
Publicado: (2022)

Immunogenicity and efficacy of vaccine boosters against SARS-CoV-2 Omicron subvariant BA.5 in male Syrian hamsters
por: Machado, Rafael R. G., et al.
Publicado: (2023)

Reproduction Number of the Omicron Variant Triples That of the Delta Variant
por: Du, Zhanwei, et al.
Publicado: (2022)

The influence of sex and diet on the characteristics of hibernation in Syrian hamsters
por: Trefna, Marie, et al.
Publicado: (2017)

Synthetic multiantigen MVA vaccine COH04S1 and variant-specific derivatives protect Syrian hamsters from SARS-CoV-2 Omicron subvariants
por: Wussow, Felix, et al.
Publicado: (2023)

Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters
por: Abdelnabi, Rana, et al.
Publicado: (2021)

Oophorectomy has no effect on experimental pancreatic carcinogenesis in the Syrian hamster.
por: Chester, J. F., et al.
Publicado: (1989)

Will New Variants Emerge after Delta and Omicron?
por: Yang, Zhen, et al.
Publicado: (2022)

Accessible standardized intracutaneous implants: pancreatic adenocarcinoma in the Syrian hamster.
por: LaMuraglia, G. M., et al.
Publicado: (1984)

Nasal irrigation efficiently attenuates SARS-CoV-2 Omicron infection, transmission and lung injury in the Syrian hamster model
por: Yuan, Lunzhi, et al.
Publicado: (2022)

Syrian hamster as an ideal animal model for evaluation of cancer immunotherapy
por: Jia, Yangyang, et al.
Publicado: (2023)

SARS-CoV-2 Interference of Influenza Virus Replication in Syrian Hamsters
por: Halfmann, Peter J, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l34k92i9vabv999up76oi625eb